Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Government Drug Pricing ‘Negotiation:’ Where We Go From Here

Dec 13 2019

• By Cathy Kelly

USPills — Democrats Throw Down The Gauntlet On Drug Pricing

Related Content

House Price 'Negotiation' Plan: It Is Even Worse Than It Sounds

Sep 25 2019

Pelosi Rx Pricing Bill Offers Big Savings, Big Drop In Drug Development – CBO

Oct 13 2019

The Absurd Innovation Debate: Dueling Views Of HR 3 Miss The Point

Dec 06 2019

Senate Drug Pricing Bill Lowers Manufacturer Discounts In Part D Catastrophic Phase

Dec 06 2019

Drug Pricing Policies Attached To Surprise Medical Billing Legislation

Dec 13 2019

Additional Topics

United States Pricing Debate Legislation Reimbursement Policy BioPharmaceutical

More from Drug Pricing

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.